← FDA Drug Approvals (Drugs@FDA)
XPOVIO
NDA · New Drug Application · Sponsor: KARYOPHARM THERAPS · Approved 2019-07-03
Drug application
- FDA Application #
NDA212306- Application type
- New Drug Application
- Brand name
- XPOVIO
- Generic name
- SELINEXOR
- Active ingredients
- SELINEXOR
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- KARYOPHARM THERAPS
- Manufacturer
- Karyopharm Therapeutics Inc.
- First approval
- 2019-07-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown